Russian regulatory system for clinical trials is consistent with international approaches
https://doi.org/10.30895/1991-2919-2023-13-4-488-492
Abstract
Clinical trials are the most important stage in the development of effective and safe medicinal products. Yu.N. Linkova, Candidate of Medical Sciences, Vice President for Clinical Research and Development at BIOCAD, shares her perspective on clinical trial regulation in the Russian Federation.
About the Author
Yu. N. Linkova
BIOCAD JSC
Russian Federation
Russian Federation
Yulia N. Linkova, Cand. Sci. (Med.)
38/1 Svyazi St., Strelna, St Petersburg 198515, Russian Federation
Supplementary files
Review
For citations:
Linkova Yu.N. Russian regulatory system for clinical trials is consistent with international approaches. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2023;13(4):488-492. (In Russ.) https://doi.org/10.30895/1991-2919-2023-13-4-488-492
Views:
555
Email this article 